GILLIAN CHOATE: Open Payments
NPI 1124354162 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 29 payments from 8 companies in 2025. Trend: 2023 $2,320 · 2024 $1,489 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 11 | $220 |
| Novartis Pharmaceuticals Corporation | 6 | $125 |
| Janssen Biotech, Inc. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Almirall LLC | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
| GENZYME CORPORATION | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
Products named: DAXXIFY, TREMFYA, Sotyktu, Seysara, COSENTYX, ILUMYA, DUPIXENT, NUZYRA.
Industry payments across TN — which companies pay providers there.
